Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16606972 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
Condition: Breast Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Doxorubicin;   Drug: Tamoxifen
2 Active, not recruiting Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer
Condition: Breast Cancer
Intervention: Biological: Blood and tumor sample

Indicates status has not been verified in more than two years